Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Impaired top-down modulation of saccadic latencies in patients with schizophrenia but not in first-degree relatives.

Schwab S, Jost M, Altorfer A.

Front Behav Neurosci. 2015 Feb 24;9:44. doi: 10.3389/fnbeh.2015.00044. eCollection 2015.

2.

Vergence eye movements in patients with schizophrenia.

Bolding MS, Lahti AC, White D, Moore C, Gurler D, Gawne TJ, Gamlin PD.

Vision Res. 2014 Sep;102:64-70. doi: 10.1016/j.visres.2014.07.008. Epub 2014 Aug 1.

3.

Association of saccade duration and saccade acceleration/deceleration asymmetry during visually guided saccade in schizophrenia patients.

Cui H, Liu XH, Wang KY, Zhu CY, Wang C, Xie XH.

PLoS One. 2014 May 16;9(5):e97308. doi: 10.1371/journal.pone.0097308. eCollection 2014.

4.

Biomarkers of bipolar disorder: specific or shared with schizophrenia?

Bellivier F, Geoffroy PA, Scott J, Schurhoff F, Leboyer M, Etain B.

Front Biosci (Elite Ed). 2013 Jun 1;5:845-63. Review.

5.

Ocular convergence deficits in schizophrenia.

Bolding MS, Lahti AC, Gawne TJ, Hopkins KB, Gurler D, Gamlin PD.

Front Psychiatry. 2012 Oct 17;3:86. doi: 10.3389/fpsyt.2012.00086. eCollection 2012.

6.

Predictive pursuit association with deficits in working memory in psychosis.

Moates AF, Ivleva EI, O'Neill HB, Krishna N, Cullum CM, Thaker GK, Tamminga CA.

Biol Psychiatry. 2012 Nov 1;72(9):752-7. doi: 10.1016/j.biopsych.2012.03.030. Epub 2012 May 2.

7.

Structural abnormalities in the cuneus associated with Herpes Simplex Virus (type 1) infection in people at ultra high risk of developing psychosis.

Whitford TJ, Wood SJ, Yung A, Cocchi L, Berger G, Shenton ME, Kubicki M, Phillips L, Velakoulis D, Yolken RH, Pantelis C, McGorry P, Amminger GP.

Schizophr Res. 2012 Mar;135(1-3):175-80. doi: 10.1016/j.schres.2011.11.003. Epub 2012 Jan 12.

8.

Conceptualization of the liability for schizophrenia: clinical implications.

Tsuang MT, Stone WS, Faraone SV.

Dialogues Clin Neurosci. 1999 Dec;1(3):153-64.

9.

The role of the cerebellum in schizophrenia: from cognition to molecular pathways.

Yeganeh-Doost P, Gruber O, Falkai P, Schmitt A.

Clinics (Sao Paulo). 2011;66 Suppl 1:71-7. Review.

10.

Effects of haloperidol on cognition in schizophrenia patients depend on baseline performance: a saccadic eye movement study.

Babin SL, Hood AJ, Wassef AA, Williams NG, Patel SS, Sereno AB.

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Aug 15;35(7):1753-64. doi: 10.1016/j.pnpbp.2011.06.004. Epub 2011 Jun 13.

11.

Neurobehavioral abnormalities in first-degree relatives of individuals with autism.

Mosconi MW, Kay M, D'Cruz AM, Guter S, Kapur K, Macmillan C, Stanford LD, Sweeney JA.

Arch Gen Psychiatry. 2010 Aug;67(8):830-40. doi: 10.1001/archgenpsychiatry.2010.87. Erratum in: Arch Gen Psychiatry. 2011 Jan;68(1):60.

12.

Eye movement dysfunction in first-degree relatives of patients with schizophrenia: a meta-analytic evaluation of candidate endophenotypes.

Calkins ME, Iacono WG, Ones DS.

Brain Cogn. 2008 Dec;68(3):436-61. doi: 10.1016/j.bandc.2008.09.001. Epub 2008 Oct 18.

13.

Neurophysiological endophenotypes across bipolar and schizophrenia psychosis.

Thaker GK.

Schizophr Bull. 2008 Jul;34(4):760-73. doi: 10.1093/schbul/sbn049. Epub 2008 May 22. Review.

14.

Premorbid characterization in schizophrenia: the Pittsburgh High Risk Study.

Keshavan MS, Diwadkar VA, Montrose DM, Stanley JA, Pettegrew JW.

World Psychiatry. 2004 Oct;3(3):163-8.

15.

Developing therapeutics for schizophrenia and other psychotic disorders.

Marek G, Merchant K.

NeuroRx. 2005 Oct;2(4):579-89. Review.

16.

Approaches for adolescents with an affected family member with schizophrenia.

Diwadkar VA, Prasad KM, Keshavan MS.

Curr Psychiatry Rep. 2004 Aug;6(4):296-302. Review.

17.

A model of smooth pursuit eye movement deficit associated with the schizophrenia phenotype.

Thaker GK, Avila MT, Hong EL, Medoff DR, Ross DE, Adami HM.

Psychophysiology. 2003 Mar;40(2):277-84.

18.

Recent advances in the genetics of schizophrenia.

Waterwort DM, Bassett AS, Brzustowicz LM.

Cell Mol Life Sci. 2002 Feb;59(2):331-48. Review.

19.

Motor deficits and schizophrenia: the evidence from neuroleptic-naïve patients and populations at risk.

Wolff AL, O'Driscoll GA.

J Psychiatry Neurosci. 1999 Sep;24(4):304-14. Review.

20.

Supplemental Content

Support Center